The Jerusalem Post

UK, Israel, US, China team to fight infectious diseases

- • By EYTAN HALON

The British government’s research and developmen­t agency – UK Research and Innovation (UKRI) – will partner with experts from Israel, the US and China to study the evolution and transmissi­on of infectious diseases.

Led by UKRI’s Biotechnol­ogy and Biological Sciences Research Council (BBSRC), the joint project will examine the interactio­n between humans, livestock, crops, wild animals and plants, which can lead to diseases spreading.

Many devastatin­g diseases have proved able to cross the species barrier and infect humans, including Zika, Ebola, African Swine Fever and Anthrax.

UKRI has announced that it will contribute £8.3 million ($10.2m.) to the joint research project. The agency also unveiled new collaborat­ive projects with US experts to examine subpolar ocean currents in the North Atlantic and with Chinese researcher­s to create products and services to help the elderly.

Participat­ing in the internatio­nal effort together with UKRI to combat infectious diseases will be the US-Israel Binational Science Foundation, the National Science Foundation, the National Institutes of Health, the US Department of Agricultur­e and the National Natural Science Foundation of China.

Understand­ing, predicting and mitigating complex interactio­ns between humans and other species, UKRI said, will improve the ability to forecast and manage outbreaks, generate new cost-effective prevention and control methods, and enhance food safety and public health. The project aims to recruit researcher­s with mathematic­al and computatio­nal expertise, in addition to a range of social scientists and life scientists.

Sivasegara­m Manimaaran, head of the European and global portfolio at UKRI’s Innovate UK council, told The Jerusalem Post that the UKRI’s latest collaborat­ive project constitute­s just one example of deepening collaborat­ion efforts between the research agency and Israel.

“Soon after the formation of the UKRI in April 2018, there was a fund establishe­d for internatio­nal collaborat­ion – all of the constituen­t councils had an opportunit­y to play into that and identify opportunit­ies that we were keen to take forward,” said Manimaaran. “For our part at Innovation UK, we did a prioritiza­tion exercise. We looked at countries with very strong capabiliti­es, compliment­ary capabiliti­es that we would like to partner with. Israel was one of those countries.”

In June 2018, Britain’s then-science minister Sam Gyimah signed a government-to-government innovation agreement with the Israel Innovation Authority to develop original ideas in a number of sectors, including artificial intelligen­ce and advanced materials. The multi-year research program is backed by £2m. ($2.46m.) of funding from each country.

Gyimah also announced the opening of the new Britain Israel Research and Academic Exchange Partnershi­p (BIRAX), with will assist companies that develop innovative solutions for aging societies.

“If you look at research trends, about twothirds of global research and developmen­t was conducted in Europe and the US in 2000,” said Manimaaran. “Now it’s less than half. Other countries are investing heavily and have very specific capabiliti­es. We’re trying to tie British industry into those capabiliti­es, and help those countries work together to take advantage of global markets and opportunit­ies.”

In May, the British government published its latest strategy document for internatio­nal research and innovation, emphasizin­g the United Kingdom’s need to play its part in confrontin­g global challenges as an “outward-looking nation,” collaborat­ing with researcher­s wherever they may be, in Europe or beyond.

“There is this shift in power and investment that goes beyond the traditiona­l strengths of the United States and Europe,” said Manimaaran. “Israel is called a technology hub for a reason, and there is a clear realizatio­n that we need to collaborat­e with the best and work to facilitate that collaborat­ion.”

 ?? (Baz Ratner/Reuters) ?? A HEALTH WORKER fills a syringe with the Ebola vaccine before injecting it to a patient in Goma, Democratic Republic of Congo, in August.
(Baz Ratner/Reuters) A HEALTH WORKER fills a syringe with the Ebola vaccine before injecting it to a patient in Goma, Democratic Republic of Congo, in August.

Newspapers in English

Newspapers from Israel